BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Choi C, Yoo GS, Cho WK, Park HC. Optimizing radiotherapy with immune checkpoint blockade in hepatocellular carcinoma. World J Gastroenterol 2019; 25(20): 2416-2429 [PMID: 31171886 DOI: 10.3748/wjg.v25.i20.2416]
URL: https://www.wjgnet.com/1948-5182/full/v25/i20/2416.htm
Number Citing Articles
1
Marta Maestri, Maria Pallozzi, Francesco Santopaolo, Lucia Cerrito, Maurizio Pompili, Antonio Gasbarrini, Francesca Romana Ponziani. Durvalumab: an investigational agent for unresectable hepatocellular carcinomaExpert Opinion on Investigational Drugs 2022; 31(4): 347 doi: 10.1080/13543784.2022.2033208
2
Yan Xia, Xin Lin, Yangyang Cheng, Huimin Xu, Jingya Zeng, Wanlin Xie, Mingzhu Wang, Yihua Sun. Characterization of Platelet Function-Related Gene Predicting Survival and Immunotherapy Efficacy in Gastric CancerFrontiers in Genetics 2022; 13 doi: 10.3389/fgene.2022.938796
3
David Tai, Su Pin Choo, Valerie Chew. Rationale of Immunotherapy in Hepatocellular Carcinoma and Its Potential BiomarkersCancers 2019; 11(12): 1926 doi: 10.3390/cancers11121926
4
Mahsa Pourhamzeh, Samieh Asadian, Hamed Mirzaei, Azita Minaei, Elahe Shahriari, Anastasia Shpichka, Hamidreza Aboulkheyr Es, Peter Timashev, Moustapha Hassan, Massoud Vosough. Novel antigens for targeted radioimmunotherapy in hepatocellular carcinomaMolecular and Cellular Biochemistry 2022;  doi: 10.1007/s11010-022-04483-4
5
Jin Hee Park, Hee Yeon Kim, Anbok Lee, Young Kyeong Seo, Il-Hwan Kim, Eun-tae Park, Mi Seon Kang, Sung Jae Park, SaeGwang Park. Enlightening the Immune Mechanism of the Abscopal Effect in a Murine HCC Model and Overcoming the Late Resistance With Anti-PD-L1International Journal of Radiation Oncology*Biology*Physics 2021; 110(2): 510 doi: 10.1016/j.ijrobp.2020.12.031
6
Sunmin Park, Won Sup Yoon, Mi Hee Jang, Chai Hong Rim. Clinical efficacy of external beam radiotherapy complementing incomplete transarterial chemoembolization for hepatocellular carcinomaInternational Journal of Radiation Biology 2020; 96(12): 1541 doi: 10.1080/09553002.2020.1830316
7
Ann-Lii Cheng, Chiun Hsu, Stephen L. Chan, Su-Pin Choo, Masatoshi Kudo. Challenges of combination therapy with immune checkpoint inhibitors for hepatocellular carcinomaJournal of Hepatology 2020; 72(2): 307 doi: 10.1016/j.jhep.2019.09.025
8
Han Ah Lee, Sunmin Park, Yeon Seok Seo, Won Sup Yoon, In‐Soo Shin, Chai Hong Rim. Surgery versus external beam radiotherapy for hepatocellular carcinoma involving the inferior vena cava or right atrium: A systematic review and meta‐analysisJournal of Hepato-Biliary-Pancreatic Sciences 2021; 28(12): 1031 doi: 10.1002/jhbp.865
9
Antonio D'Alessio, Lorenza Rimassa, Alessio Cortellini, David James Pinato. PD-1 Blockade for Hepatocellular Carcinoma: Current Research and Future ProspectsJournal of Hepatocellular Carcinoma 2021; : 887 doi: 10.2147/JHC.S284440
10
Sung-Won Shin, Kyungmi Yang, Miso Lee, Jiyoung Moon, Arang Son, Yeeun Kim, Suha Choi, Do-hyung Kim, Changhoon Choi, Nohyun Lee, Hee Chul Park. Manganese Ferrite Nanoparticles Enhance the Sensitivity of Hepa1-6 Hepatocellular Carcinoma to Radiation by Remodeling Tumor MicroenvironmentsInternational Journal of Molecular Sciences 2021; 22(5): 2637 doi: 10.3390/ijms22052637
11
Luis A. Pérez-Romasanta, Elisabet González-Del Portillo, Ana Rodríguez-Gutiérrez, Ángela Matías-Pérez. Stereotactic Radiotherapy for Hepatocellular Carcinoma, Radiosensitization Strategies and Radiation-Immunotherapy CombinationCancers 2021; 13(2): 192 doi: 10.3390/cancers13020192
12
Vincenzo Quagliariello, Margherita Passariello, Domenica Rea, Antonio Barbieri, Martina Iovine, Annamaria Bonelli, Antonietta Caronna, Gerardo Botti, Claudia De Lorenzo, Nicola Maurea. Evidences of CTLA-4 and PD-1 Blocking Agents-Induced Cardiotoxicity in Cellular and Preclinical ModelsJournal of Personalized Medicine 2020; 10(4): 179 doi: 10.3390/jpm10040179
13
Kyoung‐Jin Kim, Hye Won Lee, Jinsil Seong. Combination therapy with anti‐T‐cell immunoglobulin and mucin‐domain containing molecule 3 and radiation improves antitumor efficacy in murine hepatocellular carcinomaJournal of Gastroenterology and Hepatology 2021; 36(5): 1357 doi: 10.1111/jgh.15319
14
Ning Sun, Jialin Zhang, Baifeng Li, Ailin Li, Mutian Lv, Chengshuo Zhang. Favorable response to multimodal treatment in hepatocellular carcinoma with inferior vena cava and right atrial tumor thrombus and left adrenal gland metastasisMedicine 2021; 100(49): e27987 doi: 10.1097/MD.0000000000027987
15
Wenzhe Yin, Jun Xu, Chao Li, Xiankui Dai, Tong Wu, Jifeng Wen. Plantamajoside inhibits the proliferation and epithelial‐to‐mesenchymal transition in hepatocellular carcinoma cells via modulating hypoxia‐inducible factor‐1α‐dependent gene expressionCell Biology International 2020; 44(8): 1616 doi: 10.1002/cbin.11354
16
Thomas Helmberger. The evolution of interventional oncology in the 21st centuryThe British Journal of Radiology 2020; 93(1113): 20200112 doi: 10.1259/bjr.20200112
17
Changhoon Choi, Yeonwoo Cho, Arang Son, Sung-Won Shin, Yeon-Ju Lee, Hee Chul Park. Therapeutic Potential of (−)-Agelamide D, a Diterpene Alkaloid from the Marine Sponge Agelas sp., as a Natural Radiosensitizer in Hepatocellular Carcinoma ModelsMarine Drugs 2020; 18(10): 500 doi: 10.3390/md18100500
18
Hye Won Lee, Kyung Joo Cho, Jun Yong Park. Current Status and Future Direction of Immunotherapy in Hepatocellular Carcinoma: What Do the Data Suggest?Immune Network 2020; 20(1) doi: 10.4110/in.2020.20.e11
19
Magalie Dosset, Elodie Lauret-Marie Joseph, Thaiz Rivera Vargas, Lionel Apetoh. Modulation of Determinant Factors to Improve Therapeutic Combinations with Immune Checkpoint InhibitorsCells 2020; 9(7): 1727 doi: 10.3390/cells9071727
20
Fang Fang, Bin Qiu, Peng Zhen, Junjie Wang. Hypofractionated Radiotherapy for Palliation of Main Portal Vein Tumor ThrombosisFrontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.882272
21
Han Ah Lee, Chai Hong Rim. Efficacy of Local Treatments for Hepatocellular Carcinoma Involving the Inferior Vena Cava and/or Right AtriumJournal of Hepatocellular Carcinoma 2020; : 435 doi: 10.2147/JHC.S285357
22
Nalee Kim, Jeong Il Yu, Hee Chul Park, Gyu Sang Yoo, Changhoon Choi, Jung Yong Hong, Ho Yeong Lim, Jeeyun Lee, Moon Seok Choi, Jung Eun Lee, Kyunga Kim. Incorporating sarcopenia and inflammation with radiation therapy in patients with hepatocellular carcinoma treated with nivolumabCancer Immunology, Immunotherapy 2021; 70(6): 1593 doi: 10.1007/s00262-020-02794-3
23
Chai Hong Rim, Hye Yoon Lee, Jung Sun Kim, Hakyoung Kim. Radiofrequency ablation and stereotactic body radiotherapy for hepatocellular carcinoma: should they clash or reconcile?International Journal of Radiation Biology 2021; 97(2): 111 doi: 10.1080/09553002.2021.1857453
24
Heather Nesbitt, Keiran Logan, Keith Thomas, Bridgeen Callan, Jinhui Gao, Thomas McKaig, Mark Taylor, Mark Love, Eleanor Stride, Anthony P. McHale, John F. Callan. Sonodynamic therapy complements PD-L1 immune checkpoint inhibition in a murine model of pancreatic cancerCancer Letters 2021; 517: 88 doi: 10.1016/j.canlet.2021.06.003
25
Kyungmi Yang, Changhoon Choi, Hayeong Cho, Won-Gyun Ahn, Shin-Yeong Kim, Sung-Won Shin, Yeeun Kim, Taekyu Jang, Nohyun Lee, Hee Chul Park. Antigen-Capturing Mesoporous Silica Nanoparticles Enhance the Radiation-Induced Abscopal Effect in Murine Hepatocellular Carcinoma Hepa1-6 ModelsPharmaceutics 2021; 13(11): 1811 doi: 10.3390/pharmaceutics13111811
26
Liang-Cheng Chen, Hon-Yi Lin, Shih-Kai Hung, Wen-Yen Chiou, Moon-Sing Lee. Role of modern radiotherapy in managing patients with hepatocellular carcinomaWorld Journal of Gastroenterology 2021; 27(20): 2434-2457 doi: 10.3748/wjg.v27.i20.2434
27
Yvonne Chiung-Fang Hsu, Jason Chia-Hsien Cheng. Radiotherapy of Liver Cancer2021; : 325 doi: 10.1007/978-981-16-1815-4_23
28
Hailong Sheng, Yan Huang, Yazhi Xiao, Zhenru Zhu, Mengying Shen, Peitao Zhou, Zeqin Guo, Jian Wang, Hui Wang, Wencong Dai, Wanjun Zhang, Jingyuan Sun, Chuanhui Cao. ATR inhibitor AZD6738 enhances the antitumor activity of radiotherapy and immune checkpoint inhibitors by potentiating the tumor immune microenvironment in hepatocellular carcinomaJournal for ImmunoTherapy of Cancer 2020; 8(1): e000340 doi: 10.1136/jitc-2019-000340
29
Jun Won Kim, Ik Jae Lee. Exploring the mythical abscopal effect: Radiation and programmed cell death protein 1 (PD-1) blockade for hepatocellular carcinomaClinical and Molecular Hepatology 2021; 27(1): 103 doi: 10.3350/cmh.2020.0297
30
Mehmet Eşref ALKIŞ, Sefa YEŞİLBAŞ. Effect of electroporation on radiotherapy treatment in human hepatocellular carcinoma cellsJournal of Physical Chemistry and Functional Materials 2021;  doi: 10.54565/jphcfum.1006281
31
Jinhong Jung, Ji Hyeon Joo, So Yeon Kim, Jin Hyoung Kim, Jonggi Choi, Danbi Lee, Ju Hyun Shim, Kang Mo Kim, Young-Suk Lim, Han Chu Lee, Jin-hong Park, Sang Min Yoon. Radiologic Response as a Prognostic Factor in Advanced Hepatocellular Carcinoma with Macroscopic Vascular Invasion after Transarterial Chemoembolization and RadiotherapyLiver Cancer 2022; 11(2): 152 doi: 10.1159/000521227
32
Dexi Zhou, Jiajie Luan, Cheng Huang, Jun Li. Tumor-Associated Macrophages in Hepatocellular Carcinoma: Friend or Foe?Gut and Liver 2021; 15(4): 500 doi: 10.5009/gnl20223
33
Hao-Tian Liu, Meng-Jie Jiang, Zhu-Jian Deng, Le Li, Jian-Li Huang, Zhen-Xiu Liu, Le-Qun Li, Jian-Hong Zhong. Immune Checkpoint Inhibitors in Hepatocellular Carcinoma: Current Progresses and ChallengesFrontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.737497
34
Yuting Qian, Long Gong, Su Li, Kun Mao, Xianming Li, Guixiang Liao. Case Report: Radiotherapy Plus Immunotherapy and Lenvatinib for the Treatment of Recurrent Hepatocellular Carcinoma With a Right Atrium and Inferior Vena Cava Tumor ThrombusFrontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.879454
35
Yifei Dai, Weijie Qiang, Kequan Lin, Yu Gui, Xun Lan, Dong Wang. An immune-related gene signature for predicting survival and immunotherapy efficacy in hepatocellular carcinomaCancer Immunology, Immunotherapy 2021; 70(4): 967 doi: 10.1007/s00262-020-02743-0
36
Gyu Sang Yoo, Jeong Il Yu, Hee Chul Park. Current role of proton beam therapy in patients with hepatocellular carcinomaInternational Journal of Gastrointestinal Intervention 2021; 10(4): 175 doi: 10.18528/ijgii210043
37
Zhihuai Wang, Adeel Ur Rehman, Xihu Qin, Chunfu Zhu, Siyuan Wu, Ihtisham Bukhari. PI3K/AKT/mTOR Pathway-Associated Genes Reveal a Putative Prognostic Signature Correlated with Immune Infiltration in Hepatocellular CarcinomaDisease Markers 2022; 2022: 1 doi: 10.1155/2022/7545666
38
Gyu Sang Yoo, Won-Gyun Ahn, Shin-Yeong Kim, Wonseok Kang, Changhoon Choi, Hee Chul Park. Radiation-induced abscopal effect and its enhancement by programmed cell death 1 blockade in the hepatocellular carcinoma: A murine model studyClinical and Molecular Hepatology 2021; 27(1): 144 doi: 10.3350/cmh.2020.0095
39
Edo Kon, Itai Benhar. Immune checkpoint inhibitor combinations: Current efforts and important aspects for successDrug Resistance Updates 2019; 45: 13 doi: 10.1016/j.drup.2019.07.004
40
Li-Bin Xu, Zhen-Guo Zhao, Song-Feng Xu, Xin-Xin Zhang, Ting Liu, Chang-You Jing, Shu-Guang Zhang, Sheng-Ji Yu. The landscape of gene mutations and clinical significance of tumor mutation burden in patients with soft tissue sarcoma who underwent surgical resection and received conventional adjuvant therapyThe International Journal of Biological Markers 2020; 35(3): 14 doi: 10.1177/1724600820925095
41
Rixiong Wang, Nan Lin, Binbin Mao, Qing Wu. The efficacy of immune checkpoint inhibitors in advanced hepatocellular carcinoma: a meta-analysis based on 40 cohorts incorporating 3697 individualsJournal of Cancer Research and Clinical Oncology 2022; 148(5): 1195 doi: 10.1007/s00432-021-03716-1
42
Wonmo Sung, Theodore S. Hong, Mark C. Poznansky, Harald Paganetti, Clemens Grassberger. Mathematical Modeling to Simulate the Effect of Adding Radiation Therapy to Immunotherapy and Application to Hepatocellular CarcinomaInternational Journal of Radiation Oncology*Biology*Physics 2022; 112(4): 1055 doi: 10.1016/j.ijrobp.2021.11.008
43
Lingling Zhu, Xianzhe Yu, Li Wang, Jiewei Liu, Zihan Qu, Honge Zhang, Lu Li, Jiang Chen, Qinghua Zhou. Angiogenesis and immune checkpoint dual blockade in combination with radiotherapy for treatment of solid cancers: opportunities and challengesOncogenesis 2021; 10(7) doi: 10.1038/s41389-021-00335-w